The aging population - is there a role for endocrine interventions?

The aging population - is there a role for endocrine interventions? / Ralf Nass, Gudmundur Johannsson, Jens S. Christiansen, John J. Kopchick, Michael O. Thorner. - (Growth Hormone & IGF Research 19 (2009) 2 (April); p. 89-100)

  • PMID: 18977675
  • DOI: 10.1016/j.ghir.2008.09.002


Abstract

The expected increase in the aging population will have a significant impact on society and the health system in the coming years and decades. Enhancing healthspan, "healthy aging", and thus extending the time that the elderly are able to function independently is a significant task and is imperative. Age-dependent changes such as weight loss, sarcopenia and anorexia, which contribute to the development of frailty in the elderly are discussed. The role of the age-dependent decrease in growth hormone secretion in this process and the potential benefits and risks of hormonal interventions to delay, prevent or reverse frailty in the elderly are reviewed.

Original document

Parameters

Science
Review
Date
1 November 2008
People
Christiansen, Jens Sandahl
Johannsson, Gudmundur
Kopchick, John J.
Nass, Ralf
Thorner, Michael O.
Country
Denmark
Sweden
United States of America
Language
English
Other organisations
Aarhus Universitetshospital - Aarhus University Hospital
Ohio University
Sahlgrenska Universitetssjukhuset - Sahlgrenska University Hospital
University of Virginia (UVA)
Medical terms
Legitimate Medical Treatment
Document category
Scientific article
Date generated
5 November 2020
Date of last modification
13 November 2020
Category
  • Legal Source
  • Education
  • Science
  • Statistics
  • History
Country & language
  • Country
  • Language
Other filters
  • ADRV
  • Legal Terms
  • Sport/IFs
  • Other organisations
  • Laboratories
  • Analytical aspects
  • Doping classes
  • Substances
  • Medical terms
  • Various
  • Version
  • Document category
  • Document type
Publication period
Origin